A Virtual Screening Approach For Identifying Plants with Anti H5N1 Neuraminidase Activity

被引:38
作者
Ikram, Nur Kusaira Khairul [1 ,2 ]
Durrant, Jacob D. [3 ,4 ]
Muchtaridi, Muchtaridi [2 ,5 ]
Zalaludin, Ayunni Salihah [1 ]
Purwitasari, Neny [5 ]
Mohamed, Nornisah [5 ]
Rahim, Aisyah Saad Abdul [5 ]
Lam, Chan Kit [5 ]
Normi, Yahaya M. [6 ]
Abd Rahman, Noorsaadah [7 ]
Amaro, Rommie E. [3 ,4 ]
Wahab, Habibah A. [1 ,2 ,5 ]
机构
[1] Minist Sci Technol & Innovat, Malaysian Inst Pharmaceut & Nutraceut, Jalan Bukit Gambir 11800, Penang, Malaysia
[2] Univ Sains Malaysia, Sch Pharmaceut Sci, Pharmaceut Design & Simulat Lab PhDs, George Town 11800, Malaysia
[3] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, La Jolla, CA 92093 USA
[5] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town 11800, Malaysia
[6] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang 43400, Selangor, Malaysia
[7] Univ Malaya, Dept Chem, Kuala Lumpur 50603, Malaysia
基金
美国国家卫生研究院;
关键词
INFLUENZA-VIRUS NEURAMINIDASE; OSELTAMIVIR-RESISTANT INFLUENZA; DRUG-LIKE MOLECULES; GARCINIA-MANGOSTANA; FORCE-FIELD; ANTIINFLUENZA AGENTS; ACCURATE DOCKING; NATURAL-PRODUCTS; A VIRUS; INHIBITORS;
D O I
10.1021/ci500405g
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Recent outbreaks of highly pathogenic and occasional drug-resistant influenza strains have highlighted the need to develop novel anti-influenza therapeutics. Here, we report computational and experimental efforts to identify influenza neuraminidase inhibitors from among the 3000 natural compounds in the Malaysian-Plants Natural-Product (NADI) database. These 3000 compounds were first docked into the neuraminidase active site. The five plants with the largest number of top predicted ligands were selected for experimental evaluation. Twelve specific compounds isolated from these five plants were shown to inhibit neuraminidase, including two compounds with IC50 values less than 92 mu M. Furthermore, four of the 12 isolated compounds had also been identified in the top 100 compounds from the virtual screen. Together, these results suggest an effective new approach for identifying bioactive plant species that will further the identification of new pharmacologically active compounds from diverse natural-product resources.
引用
收藏
页码:308 / 316
页数:9
相关论文
共 66 条
  • [1] Mechanism of 150-cavity formation in influenza neuraminidase
    Amaro, Rommie E.
    Swift, Robert V.
    Votapka, Lane
    Li, Wilfred W.
    Walker, Ross C.
    Bush, Robin M.
    [J]. NATURE COMMUNICATIONS, 2011, 2
  • [2] Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery
    Blundell, TL
    Sibanda, BL
    Montalvao, RW
    Brewerton, S
    Chelliah, V
    Worth, CL
    Harmer, NJ
    Davies, O
    Burke, D
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2006, 361 (1467) : 413 - 423
  • [3] THE 2.2-A RESOLUTION CRYSTAL-STRUCTURE OF INFLUENZA-B NEURAMINIDASE AND ITS COMPLEX WITH SIALIC-ACID
    BURMEISTER, WP
    RUIGROK, RWH
    CUSACK, S
    [J]. EMBO JOURNAL, 1992, 11 (01) : 49 - 56
  • [4] The Binding Database: data management and interface design
    Chen, X
    Lin, YM
    Liu, M
    Gilson, MK
    [J]. BIOINFORMATICS, 2002, 18 (01) : 130 - 139
  • [5] INFLUENZA-VIRUS NEURAMINIDASE - STRUCTURE, ANTIBODIES, AND INHIBITORS
    COLMAN, PM
    [J]. PROTEIN SCIENCE, 1994, 3 (10) : 1687 - 1696
  • [6] UK stocks up on antiviral drug to tackle flu outbreak
    Coombes, R
    [J]. BRITISH MEDICAL JOURNAL, 2005, 330 (7490): : 495 - 495
  • [7] Dave K, 2011, CURR COMPUT-AID DRUG, V7, P255
  • [8] Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team
    Dawood, Fatimah S.
    Jain, Seema
    Finelli, Lyn
    Shaw, Michael W.
    Lindstrom, Stephen
    Garten, Rebecca J.
    Gubareva, Larisa V.
    Xu, Xiyan
    Bridges, Carolyn B.
    Uyeki, Timothy M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (25) : 2605 - 2615
  • [9] Antiviral agents active against influenza A viruses
    De Clercq, Erik
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (12) : 1015 - 1025
  • [10] Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection
    de Jong, MD
    Thanh, TT
    Khanh, TH
    Hien, VM
    Smith, GJD
    Chau, NV
    Cam, BV
    Qui, PT
    Ha, DQ
    Guan, Y
    Peiris, JSM
    Hien, TT
    Farrar, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) : 2667 - 2672